Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ISRADIPINE vs IVERMECTIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ISRADIPINE vs IVERMECTIN: Safety Overview

Metric ISRADIPINE IVERMECTIN
Total FAERS Reports 119 3,018
Deaths Reported 14 221
Death Rate 11.8% 7.3%
Hospitalizations 72 600
Average Patient Age 55.5 yrs 53.3 yrs
% Female Patients 46.3% 59.7%
FDA Approval Date Apr 24, 2006 Apr 13, 2020
Manufacturer Teva Pharmaceuticals USA, Inc. Asclemed USA, Inc.
Route ORAL ORAL
Marketing Status Discontinued Discontinued